Загрузка...
Evaluating a novel treatment for coronary artery inflammation in acute Kawasaki disease: A Phase I/IIa trial of atorvastatin
INTRODUCTION: Since the 1980s, the primary treatment of acute Kawasaki disease (KD) has been intravenous immunoglobulin and aspirin. However, 5-10% of children with acute KD will develop coronary artery abnormalities despite treatment within the first ten days after fever onset. There is no approved...
Сохранить в:
| Опубликовано в: : | Expert Opin Orphan Drugs |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4979608/ https://ncbi.nlm.nih.gov/pubmed/27525197 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/21678707.2015.1066246 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|